1. Home
  2. TACT vs PLUR Comparison

TACT vs PLUR Comparison

Compare TACT & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$4.14

Market Cap

41.6M

Sector

Technology

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.54

Market Cap

34.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TACT
PLUR
Founded
1996
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.6M
34.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TACT
PLUR
Price
$4.14
$3.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$12.00
AVG Volume (30 Days)
54.8K
44.2K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,258,000.00
$1,326,000.00
Revenue This Year
$21.67
$97.38
Revenue Next Year
$7.63
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
8.27
121.74
52 Week Low
$3.12
$2.82
52 Week High
$5.70
$7.13

Technical Indicators

Market Signals
Indicator
TACT
PLUR
Relative Strength Index (RSI) 38.07 48.89
Support Level $4.01 $2.82
Resistance Level $4.61 $3.72
Average True Range (ATR) 0.16 0.33
MACD -0.02 0.02
Stochastic Oscillator 20.93 52.73

Price Performance

Historical Comparison
TACT
PLUR

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: